p21 facilitates chronic lung inflammation via epithelial and endothelial cells

Aging (Albany NY). 2023 Mar 30;15(7):2395-2417. doi: 10.18632/aging.204622. Epub 2023 Mar 30.

Abstract

Cellular senescence is a stable state of cell cycle arrest that regulates tissue integrity and protects the organism from tumorigenesis. However, the accumulation of senescent cells during aging contributes to age-related pathologies. One such pathology is chronic lung inflammation. p21 (CDKN1A) regulates cellular senescence via inhibition of cyclin-dependent kinases (CDKs). However, its role in chronic lung inflammation and functional impact on chronic lung disease, where senescent cells accumulate, is less understood. To elucidate the role of p21 in chronic lung inflammation, we subjected p21 knockout (p21-/-) mice to repetitive inhalations of lipopolysaccharide (LPS), an exposure that leads to chronic bronchitis and accumulation of senescent cells. p21 knockout led to a reduced presence of senescent cells, alleviated the pathological manifestations of chronic lung inflammation, and improved the fitness of the mice. The expression profiling of the lung cells revealed that resident epithelial and endothelial cells, but not immune cells, play a significant role in mediating the p21-dependent inflammatory response following chronic LPS exposure. Our results implicate p21 as a critical regulator of chronic bronchitis and a driver of chronic airway inflammation and lung destruction.

Keywords: cellular senescence; chronic lung inflammation; p21 (CDKN1A).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchitis, Chronic* / genetics
  • Cell Cycle
  • Cellular Senescence / physiology
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Endothelial Cells / metabolism
  • Inflammation
  • Lipopolysaccharides / toxicity
  • Mice
  • Pneumonia* / metabolism

Substances

  • Lipopolysaccharides
  • Cyclin-Dependent Kinase Inhibitor p21